Article
Generation of a stable thrombin-activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation.
Journal of thrombosis and haemostasis : JTH - 1 Jun 2015
Zhou X, Declerck P J
Abstract excerpt
BACKGROUND: Thrombin-activatable fibrinolysis inhibitor (TAFI) is a zymogen that can be activated to form activated TAFI (TAFIa) (Ala93-Val401) through removal of the N-terminal activation peptide (Phe1-Arg92). TAFIa is thermally unstable, and the role of the activation peptide in the activity and stability of TAFI zymogen remains unclear. OBJECTIVES: To better understand the role of the activation peptide in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
